Skip to main content
 Sarah Bridges

Sarah Bridges

Trial Manager

+44 (0)29 2068 7201
6th Floor, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS


I am the Trial Manager for the SCOPE2 trial, a multi-centre randomised Phase II/III study of radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemoradiotherapy (with an embedded Phase II study of an additional PET scan informing chemotherapy regimen in patients with poor early response).

I also manage the FOLFERA trial, which is a closed randomised Phase II study of the addition of an endothelin receptor antagonist to the FOLFIRI chemotherapy regimen in patients with metastatic colorectal cancer after failure of an oxaliplatin-containing regimen.



Areas of expertise